Delphi
Services--Dennis E. Vaccaro, Ph.D., President
Delphi Services provides
consultation on business, regulatory affairs, and technical issues for companies
focused on the life sciences. The firm has particular experience with startups--including
both new product lines/divisions within established companies as well as starting
new companies. The principals have had extensive experience managing successful
and highly profitable companies. In addition, they have written numerous articles
and books analyzing technologies and products in the pharmaceutical arena. The
principals have served on the boards of several small companies in active management
roles.
Haberman
Associates--Allan B. Haberman, Ph.D., Principal
Haberman Associates is
a consulting firm specializing in science and technology strategy for life science
companies. The firm assists its clients in biotechnology, pharmaceutical, and
other life science companies to discover and develop new drugs and other life
science products, improve their drug pipelines, gain partners for their drug development
and technology projects, develop new applications for their technologies, and
penetrate new markets.
SciGro, Inc.--Betsy Ohlsson-Wilhelm Ph.D. and Katharine Muirhead, Ph.D. Principals
SciGro, Inc., founded in 1996, specializes in services supporting rapid translation
of research and preclinical stage technology into viable products for the pharmaceutical,
biotechnology, medical diagnostics, and life sciences industries. Typical clients
include investors, founders, CEOs, CSOs, and licensing, technology development,
or business development officers. SciGro principals combine expertise in a broad
range of scientific disciplines with senior level biomedical industry and technology
transfer experience, and bring both to bear on the challenge of designing and
implementing effective development strategies. SciGro services include early stage
technology and product management, opportunity and technology assessment, and
licensing support. Clients use SciGro to help speed their transition from research
to development, add specialized expertise, and leverage the capabilities of critical
personnel while conserving resources and maintaining focused growth.
Slanetz
Associates--Alfred E. Slanetz, Ph.D., Principal
Slanetz Associates is
focused on business development, finance, strategic planning, and scientific and
product planning for the biotechnology industry. Its principals have both a scientific
and a commercial background, having served as executive officers of major biotechnology
companies in the United States and in Europe. They have been responsible for multiple
public and private equity financings and strategic partnerships with pharmaceutical
companies, other biotechnology companies, and universities in the United States,
Europe, and Japan. The firm maintains senior level contacts at major institutions
worldwide.
Trilogy
Associates--Joseph J. Kalinowski, Principal
Trilogy Associates is a business
development and management consulting firm that facilitates business growth through
commercialization of new products. Trilogy, founded in 1989, serves clients active
in medical, bioscience, and certain industrial markets with a staff of four senior
associates, all of whom have experiences combining successful industrial management
roles with management/technology consulting accomplishments. Typically operating
at the intersection of market acumen and technology development, Trilogy counsels
and directly supports its clients by developing and implementing systematic growth
strategies, frequently including the identification and assessment of new product
opportunities. Trilogy's industry experience includes drug discovery, laboratory
equipment and supplies, analytical instrumentation, medical devices, clinical
diagnostics, patient monitoring, informatics, medical imaging, and a variety of
industrial components, materials, monitoring, and control products.
If
you have any questions about the Biopharmaceutical Consortium, its services, or
its member firms, please contact Allan
B. Haberman, Principal, Haberman Associates.
